2005
DOI: 10.1016/j.forsciint.2004.12.011
|View full text |Cite
|
Sign up to set email alerts
|

Validation of a 21-locus autosomal SNP multiplex for forensic identification purposes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
56
0
1

Year Published

2006
2006
2016
2016

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 95 publications
(60 citation statements)
references
References 29 publications
3
56
0
1
Order By: Relevance
“…Such results from challenging DNA emphasize the importance of methodologies using reduced amplicon sizes to analyze severely degraded DNA, in line with success rates observed for other short-amplicon genotyping approaches based on SNPs or miniSTRs (e.g. [11,13,24,25]). …”
Section: Multiplex Performancesupporting
confidence: 57%
“…Such results from challenging DNA emphasize the importance of methodologies using reduced amplicon sizes to analyze severely degraded DNA, in line with success rates observed for other short-amplicon genotyping approaches based on SNPs or miniSTRs (e.g. [11,13,24,25]). …”
Section: Multiplex Performancesupporting
confidence: 57%
“…Until now, only a few large multiplexes have been reported [26], but larger multiplexes that are constructed based on the same principles as the present 52-plex are emerging, e.g. packages with Y chromosome SNPs [15,27] Furthermore, we are also implementing the 52-plex into alternative MALDI-TOF-based assays [28], conventional microarrays and oligonucleotide ligation-based assays.…”
Section: Discussionmentioning
confidence: 96%
“…These loci are highly polymorphic, localized in non-coding regions which are on different chromosomes. As an improvement in their efficiency, the new multiplexes that amplify 16 loci or more, in a single reaction (including amelogenin too), have been introduced in the last years [15]. The most common STR kits used in the forensic laboratories for the identification are manufactured by three companies: Life Technologies, Promega and Qiagen.…”
Section: Autosomal Str Profilingmentioning
confidence: 99%